drugset / Trial / NCT03006952
Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy
RandomizedParallel-groupOpen-labelPrevention
Summary
This study was designed to assess the efficacy of adding pentoxifylline to losartan in comparison with increasing dose of losartan in type 2 diabetes patients with nephropathy. also the effect of pentoxifylline on N terminal brain natriuretic peptide (NT-pro BNP) and C-reactive protein
Timeline
- Start
- 2015-04
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Losartan | Other / unclassified | 50 mg | — |
| Comparator | Losartan | Other / unclassified | 100 mg | — |
| Comparator | Pentoxifylline | Small molecule | 400 mg | — |